Pimozide, a neuroleptic drug, has been studied in cancers due to its mechanism of action inhibiting the JAK/STAT signaling pathway, specifically by suppressing the phosphorylation/activation of STAT proteins, particularly STAT5 [51]. The gene discussed is SOAT1; the disease is cancer.